International Journal of Pharmacology1811-77751812-5700Asian Network for Scientific Information10.3923/ijp.2018.285.290Ibrahim Al-SaikhanFahad Abd-Elghany Abd-ElazizMohamed Hamdy AshourRehab LangaeeTaimour 22018142Background and Objective: Thoughtful evaluation of patients knowledge, satisfaction and concerns in anticoagulation clinics helps to understand areas of improvement. This study aimed to examine patients drug knowledge, satisfaction and concerns with provided anticoagulation services. Materials and Methods: This study was designed as a cross-sectional survey that was developed and conducted in a regional anticoagulation clinic with good number of patients. Two hundred sixty eight were recruited in the survey. Patients warfarin refill records and time within the therapeutic INR range were retrieved from hospital databases. All statistical assessment and analysis were carried out with SPSS. Results: Adequate knowledge of warfarin-food and warfarin-drug interactions was lacking in about 50% of patients. Satisfaction with provided service was not optimal. Concerns associated with warfarin was bothersome to many patients due to possible drug-drug interactions (41.42%), missed doses impact (29.10%), adverse drug reactions (29.85%). All of which might lead to unfavorable consequences. Higher satisfaction was associated with better knowledge (r = 0.27, p = 0.001) and fewer concerns (rs = - 0.26, p = 0.002). Improved drug-related knowledge and higher satisfaction were positively reflected in these patients attitude toward drug use compliance in knowledge (rs = 0.23, p = 0.01) and satisfaction (rs = 0.19, p = 0.041). Eventually, good INR control was shown more with better knowledge, higher satisfaction and better warfarin adherence (p = 0.004, 0.03, 0.04 and 0.004, respectively). Conclusion: There is a deficit in patients knowledge and satisfaction with warfarin therapy. Such deficits lifted the threshold of concerns with warfarin use and negatively affected INR control.]]>Ansell, J., J. Hirsh, L. Poller, H. Bussey, A. Jacobson and E. Hylek,2004126204S233SHylek, E.M., A.S. Go, Y. Chang, N.G. Jensvold, L.E. Henault, J.V. Selby and D.E. Singer,200334910191026Levine, M.N., G. Raskob, R.J. Beyth, C. Kearon and S. Schulman,2004126287S310SMerli, G.J. and G. Tzanis,200927293299Krynetskiy, E. and P. McDonnell,2007322427434Wang, Y., M.C. Kong and Y. Ko,201336416421Tang, E.O.Y.L., C.S.M. Lai, K.K.C. Lee, R.S.M. Wong, G. Cheng and T.Y.K. Chan,2003373439Sturgess, I.K., C.M. Hughes and J.C. McElnay,2000265R35R35Hess, L.M., M.A. Raebel, D.A. Conner and D.C. Malone,20064012801288Smith, M.B., N. Christensen, S. Wang, J. Strohecker and J.D. Day et al.,20101166169Wang, Y., M.C. Kong, L.H. Lee, H.J. Ng and Y. Ko,2014133550554Davis, N.J., H.H. Billett, H.W. Cohen and J.H. Arnsten,200539632636Kurnik, D., R. Loebstein, H. Rabinovitz, N. Austerweil, H. Halkin and S. Almog,20041-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients A prospective, controlled trial.]]>9210181024Juurlink, D.N.,2007177369371Voller, H., C. Dovifat, J. Glatz, H. Kortke, U. Taborski and K. Wegscheider,200411442447Morsdorf, S., W. Erdlenbruch, U. Taborski, J.F. Schenk and K. Erdlenbruch et al.,199925109115Kulinna, W., D. Ney, T. Wenzel, D.L. Heene and J. Harenberg,199925123126Aquilante, C.L., T.Y. Langaee, L.M. Lopez, H.N. Yarandi and J.S. Tromberg et al.,200679291302Sconce, E.A., T.I. Khan, H.A. Wynne, P. Avery and L. Monkhouse et al.,2005CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen.]]>10623292333